Cargando…

CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer

SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite s...

Descripción completa

Detalles Bibliográficos
Autores principales: Karjula, Topias, Elomaa, Hanna, Niskakangas, Anne, Mustonen, Olli, Puro, Iiris, Kuopio, Teijo, Ahtiainen, Maarit, Mecklin, Jukka-Pekka, Seppälä, Toni T., Wirta, Erkki-Ville, Sihvo, Eero, Väyrynen, Juha P., Yannopoulos, Fredrik, Helminen, Olli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818882/
https://www.ncbi.nlm.nih.gov/pubmed/36612204
http://dx.doi.org/10.3390/cancers15010206
_version_ 1784865094757253120
author Karjula, Topias
Elomaa, Hanna
Niskakangas, Anne
Mustonen, Olli
Puro, Iiris
Kuopio, Teijo
Ahtiainen, Maarit
Mecklin, Jukka-Pekka
Seppälä, Toni T.
Wirta, Erkki-Ville
Sihvo, Eero
Väyrynen, Juha P.
Yannopoulos, Fredrik
Helminen, Olli
author_facet Karjula, Topias
Elomaa, Hanna
Niskakangas, Anne
Mustonen, Olli
Puro, Iiris
Kuopio, Teijo
Ahtiainen, Maarit
Mecklin, Jukka-Pekka
Seppälä, Toni T.
Wirta, Erkki-Ville
Sihvo, Eero
Väyrynen, Juha P.
Yannopoulos, Fredrik
Helminen, Olli
author_sort Karjula, Topias
collection PubMed
description SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite stable CRC. The T-cell infiltration was higher in the first pulmonary metastases compared to primary tumour. Pulmonary metastases with high ICS had improved survival compared to low ICS after adjusting for confounders. High tumour cell PD-L1 expression was associated with favourable prognosis. Our results might have clinical feasibility in planning future therapies. ABSTRACT: The objective of this study was to evaluate the prognostic value of CD3(+) and CD8(+) based immune cell score (ICS), programmed death -1 (PD-1) and programmed death ligand -1 (PD-L1) in pulmonary metastases of proficient mismatch repair colorectal cancer (CRC) patients. A total of 101 pulmonary metastases and 62 primary CRC tumours were stained for CD3(+), CD8(+), PD-1 and PD-L1 expression. The prognostic value of ICS, PD-1/PD-L1 expression in 67 first pulmonary metastases and 61 primary CRC tumour was analysed. Comparative analysis was also performed between primary tumours and pulmonary metastases, as well as between T-cell densities and PD-1/PD-L1 expression. The 5-year overall survival rates of low, intermediate, and high ICS in pulmonary metastases were 10.0%, 25.5% and 47.0% (p = 0.046), respectively. Patients with high vs. low ICS in pulmonary metastases had a significantly better 5-year survival (adjusted HR 0.25, 95% CI 0.09–0.75, p = 0.013). High tumour cell PD-L1 expression in the pulmonary metastases was associated with improved survival (p = 0.024). Primary tumour CD8(+) expression was significantly correlated with all T-cell densities in pulmonary metastases. Conclusion: The ICS evaluated from the resected pulmonary metastases of CRC showed significant prognostic value. High PD-L1 expression in pulmonary metastases is associated with favourable prognosis.
format Online
Article
Text
id pubmed-9818882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98188822023-01-07 CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer Karjula, Topias Elomaa, Hanna Niskakangas, Anne Mustonen, Olli Puro, Iiris Kuopio, Teijo Ahtiainen, Maarit Mecklin, Jukka-Pekka Seppälä, Toni T. Wirta, Erkki-Ville Sihvo, Eero Väyrynen, Juha P. Yannopoulos, Fredrik Helminen, Olli Cancers (Basel) Article SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite stable CRC. The T-cell infiltration was higher in the first pulmonary metastases compared to primary tumour. Pulmonary metastases with high ICS had improved survival compared to low ICS after adjusting for confounders. High tumour cell PD-L1 expression was associated with favourable prognosis. Our results might have clinical feasibility in planning future therapies. ABSTRACT: The objective of this study was to evaluate the prognostic value of CD3(+) and CD8(+) based immune cell score (ICS), programmed death -1 (PD-1) and programmed death ligand -1 (PD-L1) in pulmonary metastases of proficient mismatch repair colorectal cancer (CRC) patients. A total of 101 pulmonary metastases and 62 primary CRC tumours were stained for CD3(+), CD8(+), PD-1 and PD-L1 expression. The prognostic value of ICS, PD-1/PD-L1 expression in 67 first pulmonary metastases and 61 primary CRC tumour was analysed. Comparative analysis was also performed between primary tumours and pulmonary metastases, as well as between T-cell densities and PD-1/PD-L1 expression. The 5-year overall survival rates of low, intermediate, and high ICS in pulmonary metastases were 10.0%, 25.5% and 47.0% (p = 0.046), respectively. Patients with high vs. low ICS in pulmonary metastases had a significantly better 5-year survival (adjusted HR 0.25, 95% CI 0.09–0.75, p = 0.013). High tumour cell PD-L1 expression in the pulmonary metastases was associated with improved survival (p = 0.024). Primary tumour CD8(+) expression was significantly correlated with all T-cell densities in pulmonary metastases. Conclusion: The ICS evaluated from the resected pulmonary metastases of CRC showed significant prognostic value. High PD-L1 expression in pulmonary metastases is associated with favourable prognosis. MDPI 2022-12-29 /pmc/articles/PMC9818882/ /pubmed/36612204 http://dx.doi.org/10.3390/cancers15010206 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Karjula, Topias
Elomaa, Hanna
Niskakangas, Anne
Mustonen, Olli
Puro, Iiris
Kuopio, Teijo
Ahtiainen, Maarit
Mecklin, Jukka-Pekka
Seppälä, Toni T.
Wirta, Erkki-Ville
Sihvo, Eero
Väyrynen, Juha P.
Yannopoulos, Fredrik
Helminen, Olli
CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title_full CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title_fullStr CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title_full_unstemmed CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title_short CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
title_sort cd3(+) and cd8(+) t-cell-based immune cell score and pd-(l)1 expression in pulmonary metastases of microsatellite stable colorectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818882/
https://www.ncbi.nlm.nih.gov/pubmed/36612204
http://dx.doi.org/10.3390/cancers15010206
work_keys_str_mv AT karjulatopias cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT elomaahanna cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT niskakangasanne cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT mustonenolli cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT puroiiris cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT kuopioteijo cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT ahtiainenmaarit cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT mecklinjukkapekka cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT seppalatonit cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT wirtaerkkiville cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT sihvoeero cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT vayrynenjuhap cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT yannopoulosfredrik cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer
AT helminenolli cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer